Table 3.
Adjusted Relationship Between Specialty of Care Provider and Treatment Strategies
| Care Process | Provider Specialty | Adjusted OR | Lower (95% CI for OR) | Upper (95% CI for OR) | P Value | Global P Value |
|---|---|---|---|---|---|---|
| Rhythm control | EP (vs cardiology) | 1.66 | 1.05 | 2.61 | 0.0301 | 0.0470 |
| FP/IM (vs cardiology) | 0.91 | 0.65 | 1.26 | 0.5512 | — | |
| Prior cardioversion | EP (vs cardiology) | 1.39 | 1.03 | 1.87 | 0.0292 | 0.0231 |
| FP/IM (vs cardiology) | 0.88 | 0.70 | 1.10 | 0.2699 | — | |
| Oral anticoagulant (warfarin or dabigatran) | EP (vs cardiology) | 1.25 | 0.71 | 2.19 | 0.4350 | 0.1500 |
| FP/IM (vs cardiology) | 0.73 | 0.49 | 1.09 | 0.1233 | — | |
| Dabigatran vs warfarin | EP (vs cardiology) | 1.11 | 0.49 | 2.50 | 0.8023 | 0.2395 |
| FP/IM (vs cardiology) | 0.61 | 0.32 | 1.13 | 0.1179 | — | |
| Antiplatelet* | EP (vs cardiology) | 1.34 | 0.93 | 1.92 | 0.1132 | <0.0001 |
| FP/IM (vs cardiology) | 0.60 | 0.47 | 0.79 | 0.0002 | — | |
| Anticoagulant clinic* | EP (vs cardiology) | 3.51 | 0.90 | 13.67 | 0.0705 | 0.0577 |
| FP/IM (vs cardiology) | 0.60 | 0.23 | 1.60 | 0.3097 | — |
OR indicates odds ratio; CI, confidence interval; EP, electrophysiology; FP, family practice; IM, internal medicine.
*
Aspirin, clopidogrel, prasugrel.
*
Analyses only among those on warfarin (n=7176).